GENEVA, April 6 (Reuters) - The World Health Organization
expects there will be no reason to change its assessment that
the benefits of the AstraZeneca vaccine against COVID-19
outweigh any risks, a regulatory official told a news conference
on Tuesday.
The WHO is closely studying the latest data alongside
European and other regulators, in light of reports of blood
clots among people who have been vaccinated, said Rogerio
Gaspar, WHO director of regulation and prequalification.
He said the WHO expects to reach a fresh assessment on
Wednesday or Thursday, but does not believe there will be a
reason to change its advice that the benefits outweigh any
risks.
(Reporting by John Miller and Stephanie Nebehay
Writing by Peter Graff; Editing by Kevin Liffey)